Both in Pharmaceuticals
Pfizer vs Regeneron Pharmaceuticals
Over the past year PFE returned +23.8% and REGN returned +42.4%; their daily moves had a correlation of 0.41.
PFE +23.8% REGN +42.4%Growth of $1, one year, split-adjusted
| Metric | PFE | REGN |
|---|---|---|
| Price | $30.52 | $927.89 |
| Market cap | $173.95B | $95.99B |
| Today | +1.90% | +13.33% |
| 1 month | +8.5% | +26.3% |
| 6 months | +15.9% | +32.3% |
| Year to date | +22.6% | +20.2% |
| 1 year | +25.6% | +42.1% |
| Revenue growth (YoY) | +2.6% | +36.3% |
| Gross margin | 72.8% | 88.8% |
| Net margin | −1.6% | 38.1% |
| P/E (TTM) | 40.2× | 19.9× |
| Price / sales | 2.7× | 5.7× |
| Net cash | -$51.49B | $6.59B |
| Dividend yield | 5.64% | 0.41% |
| Volatility (60d) | 19.8% | 37.0% |
| Short % of float | 2.4% | 2.2% |
| Next earnings | Nov 3, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).